MTOR and early-onset autosomal dominant Alzheimer disease: Treatment with rapamycin or rapalogs in mice with Alzheimer's disease reduces cognitive deterioration [111, 112], suggesting that inhibitors of mTOR can potentially heal age-related disorders though adverse effects (such as immune system suppression) are inevitable.